323 - Take-Home Naloxone in the Pediatric Emergency Department Setting: Feasibility Demonstration

A p</span>rocess map was generated and implemented (Figure 1). Briefly, universal passive screening was conducted via large, digital message displays in the waiting area and via computer screensavers in individual ED exam rooms. Public health and child safety content messages were displayed for alternating weeks among an ongoing rotation of other unrelated informational messages. Family requests were directed to the bedside nurse. The bedside nurse retrieved the naloxone kit from a secure storage area within the ED, provided brief education to family, and then documented education within the medical record for tracking purposes. During the initial six-week pilot period in late fall 2022, seven naloxone kits were distributed, six during public health message weeks and one during child safety message weeks (Figure 2). All nurses who completed feedback forms agreed that the program was acceptable. 


Conclusion(s): This pilot suggests that naloxone distribution in a pediatric ED setting is feasible and acceptable. While it is not possible to draw firm conclusions regarding the relative efficacy of the different motivating themes, initial signal suggests that a public health focus may be more effective in motivating family requests for naloxone from a pediatric ED setting. Continuous review and iteration of the pilot is ongoing.